New clinical trial registered: InSightec has registered a two-arm, open-label study to establish safety & feasibility of intracerebral delivery of GCase (via MR-guided focused ultrasound) in 14 individuals with Parkinsons (7 GBA-PD & 7 iPD)
Official Title: A Phase I/II Study for Bilateral Putamenal Delivery of Recombinant Glucocerebrosidase in Patients With Parkinson's Disease Using MR-guided Focused Ultrasound Induced Opening of the Blood-brain Barrier
Estimated Study Completion Date: December 31, 2023
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.